Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center、Randomize、Open、Non-inferiority Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD

NCT03277001 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT03277001
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03277001 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center、Randomize、Open、Non-inferiority Study of Prophylactic Effect of Rivaroxaban on Venous Thromboembolism in AECOPD
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2017
Completion date
December 31, 2019
Enrollment
438 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute exacerbation copd, venous thromboembolism